Hovione and Vertex Pharma have teamed up to set a continuous manufacturing facility at the former's site in New Jersey, US. The project - which is scheduled to be completed before the end of 2017 - is designed to support production of Vertex's approved medicines.

Read the article
Read Hovione's press release